RC48-ADC Combined With Bevacizumab in HER2-positive Advanced Colorectal Cancer
Clinical trial NCT05785325 · UNKNOWN
Trial details
- NCT number
- NCT05785325
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-20
- Primary completion
- 2023-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.